Pfizer Inc. news

   Watch this stock
Showing stories 11 - 20 of about 179   

Articles published

PFE 31.97 +0.61 (1.95%)
price chart
Pfizer Gets US Approval to Acquire Hospira
Pfizer Inc. PFE -2.67 % on Monday said U.S. regulators have approved its acquisition of smaller rival Hospira Inc., HSP -0.01 % pending the divestiture of some sterile injectable drugs, putting the deal on track to close in early September.
Pfizer Inc. To Complete Hospira, Inc. Acquisition Next Month  Bidness ETC
5 Things Pfizer inc. Wants You to Know
Pfizer (NYSE: PFE ) , arguably the preeminent name among Big Pharma companies, reported its second-quarter results roughly two weeks ago and handily surpassed Wall Street's expectations for a change.
HiFiBiO SAS Achieves Milestone in Antibody Research Collaboration with Pfizer Inc.
PARIS, Aug 13, 2015 (BUSINESS WIRE) -- HiFiBiO SAS announced today the company has achieved a milestone in its research collaboration with Pfizer Inc., triggering a milestone payment to HiFiBiO. The focus of the collaboration, originally signed in 2014 ...
Interesting October Stock Options for Pfizer
Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Pfizer Inc (Symbol: PFE). So this week we highlight one interesting put contract, and one interesting call contract, from the ...
Pfizer Inc. Sells Off 4 Drugs To Alvogen: A Smart Decision?
Pfizer is focusing on the long-term benefits that would result from the Hospira purchase, as the company seeks to retain its status as the world's largest drug-maker.
Pfizer says Hospira purchase will close in early September  Beloit Daily News
Pfizer Late-Stage Meningitis B Drug Studies Meet Endpoints
Pfizer Inc. PFE -2.67 % said Friday that two late-stage studies for its Trumenba meningitis B vaccine met their primary endpoint goals, showing “robust immune responses” against some strains of meningococcal disease.
Pfizer Inc. (NYSE:PFE) Stands Firm Against Stockholders Demands with Bristol ...
Pfizer Inc. (NYSE:PFE) [Detail Analytic Report] has disclosed that the firm will resist demands from shareholders and transparency campaigners that it reveal results from all historical drug trials.
Why M&A Doesn't Make Sense For Pfizer Anytime Soon
In a report published Wednesday, Bank of America analyst Colin Bristow detailed an investor meeting held with Pfizer Inc. (NYSE: PFE)'s CEO Ian Read and other key senior executives.
Better Dividend Stock: Johnson & Johnson vs. Pfizer Inc.
Pfizer slashed its dividend payout back in 2009 during the global financial crisis. While the company's dividend has grown since then, Pfizer's dividend still isn't back up to pre-crisis levels. Meanwhile, J&J has steadily increased its dividend payout ...
Pfizer Inc. (PFE) Closes 1.35% Down on the Day for August 31
Dow Jones component Pfizer Inc. (PFE) saw its stock move -1.35% to $32.22, representing a per-share move of $0.44, on volume of 31.9 million shares for Monday.
Should You Sell GE, AT&T, Pfizer? Check Weekly Charts  Nasdaq